On the subject of Sputnik V manufacturing, Serum Insitute has sought the DCGI’s permission for test analysis and examination. In case, it receives a go-ahead, an emergency use authorisation (EUA) would be required.
Vaccine manufacturer giant Serum Insitute of India (SII) on Thursday has sought legal protection from any claims linked to the use of their COVID-19 vaccines, reported news agency ANI. Meanwhile, it also has applied to get a nod from the Drug Controller General of India (DCGI) to make the Sputnik V COVID-19 vaccine in India that is currently being manufactured by Hyderabad-based Dr. Reddy’s Laboratories.
— NDTV (@ndtv) June 3, 2021
SII’s indemnity request comes after Moderna and Pfizer have reiterated this demand to the Centre as far as their vaccines are concerned.
All vaccine makers, whether Indian or foreign, should be granted the same protection, the Adar Poonawalla-led company has reportedly told the government.
“Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” Serum sources said to NDTV today, adding that rules should be the same for everyone.
So far, the Central government hasn’t provided any protection against legal action for any severe side effects to vaccine manufacturers.
Yesterday, Health Ministry sources said other countries have granted this concession and “there is no problem” in granting indemnity or legal protection from any claims linked to the use of a company’s COVID-19 vaccine.
Also Read: DCGI Relaxes Norms For Clearing Foreign Vaccines, Pfizer, Moderna A Step Closer
Recently, India received its latest consignment of nearly 3 million doses of the Sputnik V from Russia, making it the third and largest delivery of the imported Covid-19 vaccines. The doses arrived on a specially-chartered freighter at Hyderabad Airport in Telangana.
India reported 1,34,154 cases, 2887 deaths and 24,26,265 jabs were administered in the last 24 hours, Union Health Ministry data showed
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.